Requip XL 4mg
Available Dosages
| SKU | 894 |
|---|---|
| Generic For | Requip XL |
| Strength | 4 mg |
| Manufacturer | GSK, Turkey |
| Active Ingredient | Ropinirole Hydrobromide |
Out Of Stock
Requip XL 4mg (Ropinirole Hydrobromide) – Affordable Requip XL Alternative
Requip XL 4 mg (Ropinirole)
Requip XL 4mg contains the main ingredient Ropinirole, which is classified as dopamine agonist drug. This medication is prescribed to treat Parkinson's disease and restless legs syndrome (RLS). It is dopamine replacement, which is a natural substance in the brain that helps you to control nerve thus control body movement.
What is Requip XL 4mg used for?
Requip XL 4mg is used to treat Parkinson’s disease. This medication should be taken under prescription, and it may have adverse effect, if you have no symptoms of illness. It’s easy to change patient`s dose from Ropinirole immediate release pills to ropinirole prolonged-release pills.
How does Requip XL 4mg work?
The active ingredient of Requip is Ropinirole belongs to medicines family called dopamine agonists that can affect the brain’s natural substance called dopamine. Low level of dopamine increases the risks of Parkinson’s disease and Ropinirole has similar effects like dopamine. Requip XL 4mg should be strictly taken under supervision of certified physician prescription and its progress should be monitored at regular interval.
Where to buy Requip XL 4mg online?
You can buy Requip XL 4mg online from premiumrxdrugs.com at a reasonable price.
What does Requip XL 4mg contains?
Requip XL 4mg contains 4mg of the active ingredient Ropinirole.
What are the side effects of Requip XL 4mg?
There are few common side effects of Requip XL 4mg such as:
- Unable to control your impulse, drive or temptation to perform an action
- Strong impulse
- Short temper
- Less sensitivity to touch
- Urgent need to urinate
- Altered or increased sexual interest
- Fever, stiff muscles, confusion, sweating, fast or irregular heartbeats
- Eating disorder or taking large amounts of food in a short time period
- Swelling in your hands, arms, feet, ankles, or lower legs
- Appetite problems
Some rare side effects of Requip XL are as follows:
- Feeling dizzy or faint, especially when you stand up suddenly (this is caused by a drop in blood pressure)
- Drowsiness or falling asleep very suddenly without feeling sleepy first (sudden sleep onset episodes)
- Mental or psychological problems such as delirium (severe confusion), delusions (unreasonable ideas) or paranoia (unreasonable suspicions).
What medications interact with Requip XL 4mg?
There are some drugs or medicinal elements that may interact with Requp XL 4mg such as:
- Kava
- Antipsychotic medications like chlorpromazine, haloperidol, thiothixene
- Any antidepressants
- Warfarin (Coumadin)
- Metoclopramide
- Ciprofloxacin (Cipro)
Inform your physician about all prescription, non-prescription, illegal, recreational, herbal, nutritional, or dietary drugs that you are taking along with Requip 4mg.
Some other drugs are also there that can influence the effectiveness. These medications drugs are omeprazole, rifampin, cimetidine, fluvoxamine, mexiletine, drugs to treat seizures (such as carbamazepine, phenobarbital), et
When should Requip XL 4mg not be used?
These you already have some conditions, then talk to your doctor before taking Requip XL 4mg. These conditions are:
- If you are breastfeeding
- If you have an intolerance to some sugars (such as lactose)
- If you are under 18 years old
- If you are pregnant or think you may be pregnant
- If you have a history of or have experienced any unusual urges and/or behaviors (such as excessive gambling or excessive sexual behavior
- If you have a serious heart complaint
- If you have a history of or currently have a serious mental health problem
How should Requip XL 4mg be taken?
The accurate dose of Requip XL 4mg tablet is based on the total daily dose of immediate-release formulation that the patient was receiving. The recommended dose for switching from Ropinirole immediate release tablets to Ropinirole prolonged-release tablets are provided by your doctor.
Missed dose of Requip XL 4mg
Do not take a double dose to make up for a missed dose. If you have forgotten to take Requip XL 4mg for one day or more, consult your physician for advice on how to start taking it again.
How should Requip XL 4mg be stored?
Do not store this drug at above 25°C. Keep Requip XL 4mg out of reach of children as well as moisture and direct heat.
What is Requip XL 4mg used for?
Requip XL 4mg contains ropinirole 4mg in a once-daily extended-release formulation for Parkinson's disease. The 4mg XL dose is used as monotherapy in moderate Parkinson's disease or as an adjunct to levodopa when greater dopaminergic stimulation is needed. Patients are typically titrated from 2mg XL to 4mg XL after 2 weeks if the lower dose provides insufficient motor control. The once-daily XL formulation provides smooth, sustained dopamine receptor stimulation throughout 24 hours.
How does ropinirole XL 4mg improve motor function in Parkinson's?
Ropinirole XL 4mg provides sustained D2/D3 receptor stimulation throughout the day, reducing the motor fluctuations that occur with immediate-release dopaminergic therapy. At 4mg/day, significant reduction in UPDRS motor scores, improved daily activity function, and reduced off-time are typical clinical responses. As levodopa adjunct, 4mg XL can reduce off-time by approximately 2 hours/day and allow a 20–30% levodopa dose reduction. The XL formulation provides more stable plasma levels than equivalent IR doses, improving motor consistency.
How should Requip XL 4mg be taken?
Requip XL 4mg is taken once daily with or after the main meal to minimise nausea. Swallow whole — never crush or split the extended-release tablet. Consistent daily timing (e.g., always with dinner) provides the most stable 24-hour blood levels. If additional dose increases are needed beyond 4mg, the dose is increased in 2mg increments at 2-week intervals up to 24mg/day maximum. Dose reduction in patients with renal impairment. Never stop abruptly — taper gradually over 1 week or longer.
Is Requip XL 4mg appropriate for early Parkinson's disease monotherapy?
Ropinirole XL 4mg is a reasonable maintenance dose for early-moderate Parkinson's disease monotherapy. Dopamine agonist monotherapy in early Parkinson's disease (particularly in younger patients) is recommended to delay levodopa therapy, thereby postponing the development of levodopa-induced motor complications (dyskinesias, wearing-off). At 4mg, meaningful motor improvement is provided for many patients. As dopamine cell loss progresses over years, higher doses or addition of levodopa becomes necessary.
Can Requip XL 4mg cause compulsive behaviours?
Yes — impulse control disorders (ICDs) are a well-documented class effect of dopamine agonists, affecting 10–20% of users. ICDs include pathological gambling, compulsive shopping, hypersexuality (hypersexual behaviour), and binge eating. They can cause devastating financial, relationship, and health consequences. Patients often do not volunteer this information — direct questioning at every clinical review is essential. ICD onset can occur at any dose including 4mg. Treatment: dose reduction or cessation of the dopamine agonist. Rarely reversible without dose adjustment.
Who should avoid Requip XL 4mg?
Avoid in patients with known impulse control disorders or a history of addictive behaviour — significantly higher ICD risk. Avoid in active psychosis or major hallucination history. Use with caution in severe cardiovascular disease. CYP1A2 inhibitors (fluvoxamine, ciprofloxacin) increase ropinirole levels — dose reduction needed. Severe CKD: avoid or dose reduce substantially. Abrupt withdrawal risk: dopamine agonist withdrawal syndrome with anxiety, panic, sweating, and worsened Parkinson's motor function — always taper gradually.
How does Requip XL 4mg compare to extended-release pramipexole 1.5mg?
Requip XL 4mg (ropinirole extended-release) and extended-release pramipexole 1.5mg are both dopamine agonists used to treat Parkinson’s disease and restless legs syndrome. They work by mimicking dopamine, a brain chemical involved in movement control. Pramipexole is generally considered more potent at lower doses, while Requip XL may offer smoother symptom control for some patients throughout the day. Both can help reduce stiffness, tremors, and movement problems. The choice depends on symptom severity, side effects, dosing response, and a doctor’s assessment of individual treatment needs.
Is Requip XL 4mg equivalent to branded Requip XL 4mg?
Yes. Generic ropinirole 4mg XL tablets are bioequivalent to branded Requip XL 4mg. Both provide the same sustained dopamine receptor agonism over 24 hours. Generic ropinirole XL offers Parkinson's patients significant cost savings without any reduction in clinical efficacy or safety — important for a condition requiring lifelong medication management.
Can I order Requip XL 4mg from PremiumRxDrugs for delivery to the USA?
Yes. PremiumRxDrugs.com ships Requip XL 4mg to the USA, UK, Australia, and many other countries. Our genuine manufacturer-verified Parkinson's medications, competitive pricing, and free worldwide shipping on qualifying orders make us a reliable international pharmacy for patients on dopamine agonist therapy.
What are the common side effects and important risks of Requip XL 4mg?
Common: nausea, somnolence, dizziness, orthostatic hypotension, peripheral oedema, and fatigue. Serious: impulse control disorders (gambling, hypersexuality, compulsive spending — ask at every review), sudden sleep attacks (driving hazard), hallucinations and psychosis (particularly in elderly), dopamine agonist withdrawal syndrome on abrupt discontinuation. At 4mg XL, side effects are generally moderate — less peak-concentration related than IR. Monitor blood pressure, weight, and mental health indicators at each visit.
What precautions are critical for Requip XL 4mg users?
Swallow whole — never break the XL tablet. Taper gradually on discontinuation — never stop abruptly. Directly ask about impulse control behaviours at every review. Warn about sleep attacks and restrict driving until safety established. Check CYP1A2 interactions (fluvoxamine, ciprofloxacin). Review dose when patient changes smoking status. Monitor orthostatic measurements. Educate carer/family members about ICDs and to report observed behavioural changes. Annual specialist review with UPDRS motor assessment. Plan levodopa addition before disease becomes severely disabling.
Login
Sign Up
Login
Sign Up